- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06731543
Development of an AF Specific Quality of Life Questionnaire: AF-PROMS (AF-PROMS)
May 5, 2026 updated by: Barts & The London NHS Trust
Development of a Condition Specific Quality of Life Scale for Atrial Fibrillation: AF-PROMS
This study is aiming to develop a Health Related Quality of Life (HRQoL) scale for patients who have atrial fibrillation (AF).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study is aiming to develop and validate a Health Related Quality of Life (HRQoL) scale for patients who have atrial fibrillation (AF).
As this questionnaire is currently under development, it is anticipated this measure will be a short questionnaire which will measure various aspects of quality of life.
Once the questionnaire has been validated further details of the final metric used and aspects of quality of life covered in the questionnaire can be provided.
Study Type
Observational
Enrollment (Actual)
206
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
London, United Kingdom, EC1A 7BE
- Barts Health NHS Trust
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Patients with atrial fibrillation (AF)
Description
Inclusion Criteria:
- Patients with atrial fibrillation (AF)
Exclusion Criteria:
- Exclude any participants who it is felt participation will cause distress.
- Exclude participants who do not give consent to take part in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients who have atrial fibrillation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
No primary outcomes will be measured
Time Frame: 5 years
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 14, 2014
Primary Completion (Actual)
October 18, 2024
Study Completion (Actual)
October 18, 2024
Study Registration Dates
First Submitted
September 14, 2015
First Submitted That Met QC Criteria
December 9, 2024
First Posted (Actual)
December 12, 2024
Study Record Updates
Last Update Posted (Actual)
May 8, 2026
Last Update Submitted That Met QC Criteria
May 5, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Version 5. 14/July/2014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.